• Applied Biological Chemistry
• /
• 제50권2호
• /
• pp.95-100
• /
• 2007

식물성장 촉진호르몬인 auxin, 식물병원성 진균을 방제하는 siderophore 그리고 cellulase를 동시에 생산하는 PGPR균이자 생물방제균인 Bacillus licheniformis K11의 cellulase의 유전자를 PCR을 이용해 pUC18에 재조합 후 E. coli DH5${\alpha}$에 cloning하였으며, 이 형질전환 된 균주를 E. coli DH5${\alpha}$(pCW 77)라 하였다. 형질전환 균주 E. coli DH5${\alpha}$(pCW 77)는 B. licheniformis K11의 1.6kb 유전자를 포함하며, 이 cellulase는 1,479 bp, 499개의 amino acid가 암호화된 것으로 추정된다. 형질전환균주가 생산하는 cellulase(CelW)는 lac 프로모터를 이용해 발현되었으며, CMC-SDS-PAGE의 방법으로 약 55 kDa의 분자량을 확인하였다. B. licheniformis K11의 cellulase는 4종의 대표적인 Bacillus spp. 들이 생산하는 cellulase의 아미노산 배열이 97% 이상 일치하였다. CelW는 carboxymethyl-cellulose(CMC) 뿐만 아니라 불용성 섬유소인 Avicel, Filter paper(Whatman$^{\circledR}$ No. 1)는 물론이고 고추역병균 P. capsici의 건조 cell wall도 분해하였다. CMC를 기질로 60$^{\circ}C$에서 효소활성이 가장 높았으며, 최적 pH는 pH 6.0이었다. 그리고 CoCl$_2$ 또는 MnSO$_4$ 첨가시 활성이 2배 이상 증가하였지만, FeCl$_3$ 또는 HgCl$_2$ 첨가 시는 활성이 20% 이하로 떨어졌고, SDS와 sodium azide 등 여러 화학 저해제들을 첨가하여도 87% 이상의 활성을 유지하였다. 이 결과들은 B. licheniformis K11이 식물뿌리에 근권 microflora형성의 중요한 요인으로 작용할 수 있고, 생물방제력을 발휘하는 식물병원성 진균의 세포벽 분해 cellulase 기능 연구를 가능케 하여 식물병의 생물학적 방제 연구에 기초가 될 것이라 생각된다.

• 대한수의학회지
• /
• 제25권1호
• /
• pp.7-17
• /
• 1985

Many investigators have been pursuing various attempts so far to produce hepatitis B surface antigen(HBsAg) vaccines using the techniques such as isolation from plasma of chronic HBsAg carrier, recombinant DNA technique or preparation of synthetic peptides specific for immunogenic determinants. Hepatitis B virus can not grow on any cell lines by the tissue culture technique at the present time. The plasma of chronic HBsAg carrier is expensive and its source is limited. The HBsAg from the recombinant DNA technique gave still very low yield. Another approach, therefore, has been initiated to develop a synthetic hepatitis B virus vaccine. The possible use of several distinct synthetic vaccines in prophylaxis can be facilitated by availability of full synthetic immunogens. Peptides synthesized for potential application as antiviral vaccines have been mostly tested in the form of conjugates with carrier proteins, although the free synthetic peptide can be immunogenic. To understand basic knowledges on the antigenicity and immunogenicity of a synthetic peptide specific for major immunogenic determinant of HBsAg, a nonapeptide, $H_2N^{139}Cys-Thr-Lys-Pro-Thr-Asp-Gly-^{146}Asn-Aba$ COOH, which corresponds to HBsAg amino acid residues 139 to 147, was synthesized by the Merrifield's solid-phase method with a slight modification. The antigenicity and immunogenicity of this specific synthetic peptide were examined comparing with purified plasma-derived natural HBsAg. The results obtained are as follows; 1. The peptide synthesized showed the identical amino acid composition to the theoretical value. The degree of purification and molecular weight were acertained by methods of high performance liquid chromatography and mass spectrometry. 2. Using m-maleimidobenzoyl-N-hydroxysuccinimide ester as a conjugating agent, the synthetic peptide was conjugated to rabbit albumin and ${\gamma}$-globulin, tetanus and diphtheria toxoids, and keyhole limpet hemocyanin. Their conjugation yields were 8.3, 9.5, 15.8, 13.5, and 11.2%, respectively. 3. The natural HBsAg was purified from plasma of chronic HBsAg carrier. By the electron microscopic observation of the purified natural HBsAg preparation, no Dane particles were observed and the preparation showed negative DNA polymerase activity. 4. Antigenicity of the synthetic peptide and the plasma-derived natural HBsAg was determined by competition radioimmunoassay using $^{125}I$-natural HBsAg. Their 50% inhibitions appeared as $90{\mu}g/ml$ and $0.12{\mu}g/ml$ for the synthetic peptide and the natural HBsAg, respectively. This indicates that the former was about 750-fold less antigenic than the latter. 5. Immunogenicity of the synthetic peptide was determined by administering the peptide-carrier conjugates into rabbits with and without Freund's complete adjuvant. Regardless the carrier proteins and adjuvant, positive immune responses to the synthetic peptide were observed. The higher antibody titers, however, were shown in the groups administered with Freund's complete adjuvant. 6. Immunizing dose 50% in mice of the various peptide-carrier conjugates was 5.47, 6.00, 65.16, 31.25 and $13.03{\mu}g/dose$ for rabbit albumin and ${\gamma}$-globulin, tetanus and diphtheria toxoids, and keyhole limpet hemocyanin, respectively, while the natural HBsAg showed $0.65{\mu}g/dose$. 7. It was postulated that homologous proteins prefer to heterologous ones as the carriers.